Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables

Contraception

Volumn 77, Issue 2, 2008, Pages 77-83

  Kluft, Cornelis ^a   Meijer, Piet ^a   LaGuardia, Katherine D ^b   Fisher, Alan C ^c  

^a TNO   (Netherlands)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Fibrin; Monophasic; Procoagulation; Prothrombin; Triphasic

Indexed keywords

CONTRACEPTIVE AGENT; D DIMER; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FIBRIN DEGRADATION PRODUCT; ORAL CONTRACEPTIVE AGENT; PLASMIN INHIBITOR; PROTEIN S; PROTHROMBIN; SEX HORMONE BINDING GLOBULIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OPEN STUDY; PATCH TEST; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HOMEOSTASIS; HUMANS; LEVONORGESTREL; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMIN; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN;

EID: 38349135126     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.10.004     Document Type: Article

References (14)

1. Kluft C., and Lansink M. Effect of oral contraceptives on hemostasis variables. Thromb Haemost 78 (1997) 315-326
2. Vandenbroucke J.P., Rosing J., Blomenkamp K.W., et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 344 (2001) 1527-1535
3. Phillips A., Demarest K., Hahn D.W., Wong F., and McGuire J.L. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 41 (1990) 399-410
4. Kluft C., Meijer P., Helmerhorst F.M., Hall H., and Creasy G. Comparison of the effects of a contraceptive patch and oral contraceptives on coagulation parameters. Presented at the International Federation of Gynecology and Obstetrics (FIGO) (2000) Abstract FC2.30.4
5. Rosing J., Tans G., Nicolaes G.A.F., et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol 97 (1997) 233-238
6. Heinemann L.A.J., Kluft C., Spannagl M., and deMaat M.P. The association between extrinsic activated protein C resistance and venous thromboembolism in women. Contraception 66 (2002) 297-304
7. De Maat M.M., de Bart A.W., Hennis B.C., et al. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 16 (1996) 1156-1162
8. European Medicines' Evaluation Agency (EMEA). Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical investigation of steroid contraceptives in women (2006), EMEA, London, UK
9. Miller G.J., Bauer K.A., Barzegar S., et al. The effect of quality and timing of venipuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost (1995) 7382-7386
10. Kyrle P.A., Eichinger S., Pabinger I., et al. Prothrombin fragment F 1+2 is not predictive for recurrent venous thromboembolism. Thromb Haemost 77 (1997) 829-833
11. The Oral Contraceptive and Hemostasis Study Group. The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study. Contraception 67 (2003) 173-185
12. Kemmeren J.M., Algra A., Meijers J.C., Bouma B.N., and Grobbee D.E. Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation. Blood Coagul Fibrinolysis 13 (2002) 373-381
13. Oelkers W.K. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61 (1996) 166-171
14. Van der Vange N., Blankenstein M.A., Kloosterboer H.J., Haspels A.A., and Thijssen J.H. Effects of seven low-dose combined oral contraceptives on sex hormone-binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 41 (1990) 345-352